Overview Dividends

(CRI) Carter’s - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1462291097

Apparel, Footwear, Accessories, Home Gear, Bedding

EPS (Earnings per Share)

EPS Growth (3y CAGR): -33.69%
EPS Trend (3y Corr): -46.1%

Last SUE: 0.11σ
Qual. Beats: 0

Revenue

Revenue Growth (3y CAGR): -6.52%
Revenue Trend (3y Corr): -26.1%

Last SUE: -1.26σ
Qual. Beats: 0

Risk via 10d forecast
Volatility	54.2%
Value at Risk 5%th	85.6%
Relative Tail Risk	-3.92%

Reward TTM
Sharpe Ratio	-0.74
Alpha	-60.71

Character TTM
Hurst Exponent	0.361
Beta	1.313
Beta Downside	0.829

Drawdowns 3y
Max DD	71.26%
Mean DD	28.89%
Median DD	22.03%

Description: CRI Carter’s November 14, 2025

Carter’s, Inc. (NYSE:CRI) designs, sources, and markets a portfolio of children’s apparel and related products-including Carter’s, OshKosh B’gosh, Skip Hop, and several licensed lines-across three operating segments: U.S. Retail, U.S. Wholesale, and International.

The company’s core offerings span baby and toddler basics (bodysuits, sleepwear, dresses) and play-time apparel (denim, overalls, knit tops) under the Carter’s and OshKosh brands, while the Skip Hop brand supplies bags, bedding, and accessories. Sales are generated through a mix of wholesale partners (department stores, specialty chains), company-owned retail locations, and direct-to-consumer channels such as carters.com, oshkosh.com, skiphop.com, and a mobile app.

Key recent metrics: FY2023 net revenue reached approximately $4.3 billion, with comparable-sales growth of 5% YoY driven largely by a 15% surge in e-commerce sales. The business benefits from a relatively low-price elasticity segment, as infant apparel demand is historically resilient to macro-economic cycles, while overall U.S. consumer discretionary spending and birth-rate trends remain primary drivers of top-line performance.

For a deeper, data-driven look at Carter’s valuation and peer benchmarks, the ValueRay platform provides a concise, analytics-focused overview.

CRI Stock Overview

Market Cap in USD	1,040m
Sub-Industry	Apparel, Accessories & Luxury Goods
IPO / Inception	2003-10-24
Return 12m vs S&P 500	-49.0%
Analyst Rating	2.33 of 5

CRI Dividends

Metric	Value
Dividend Yield	8.21%
Yield on Cost 5y	3.09%
Yield CAGR 5y	51.97%
Payout Consistency	94.2%
Payout Ratio	39.1%

CRI Growth Ratios

Metric	Value
CAGR 3y	-24.32%
CAGR/Max DD Calmar Ratio	-0.34
CAGR/Mean DD Pain Ratio	-0.84
Current Volume	889.1k
Average Volume	1128.4k

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (89.1m TTM) > 0 and > 6% of Revenue (6% = 170.0m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -7.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 22.31% (prev 20.67%; Δ 1.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 151.2m > Net Income 89.1m (YES >=105%, WARN >=100%)

Net Debt (994.2m) to EBITDA (199.5m) ratio: 4.98 <= 3.0 (WARN <= 3.5)

Current Ratio 2.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (35.4m) change vs 12m ago 0.40% (target <= -2.0% for YES)

Gross Margin 46.79% (prev 48.28%; Δ -1.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 116.9% (prev 119.5%; Δ -2.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 4.66 (EBITDA TTM 199.5m / Interest Expense TTM 31.0m) >= 6 (WARN >= 3)

Altman Z'' 3.79

(A) 0.26 = (Total Current Assets 1.13b - Total Current Liabilities 501.7m) / Total Assets 2.47b

(B) 0.35 = Retained Earnings (Balance) 874.4m / Total Assets 2.47b

(D) 0.53 = Book Value of Equity 846.6m / Total Liabilities 1.60b

Total Rating: 3.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 50.09

1. Piotroski 2.50pt = -2.50

2. FCF Yield 4.52% = 2.26

3. FCF Margin 3.25% = 0.81

4. Debt/Equity 1.36 = 1.64

5. Debt/Ebitda 4.98 = -2.50

6. ROIC - WACC (= 3.01)% = 3.77

7. RoE 10.42% = 0.87

8. Rev. Trend -26.06% = -1.95

9. EPS Trend -46.07% = -2.30

What is the price of CRI shares?

As of November 21, 2025, the stock is trading at USD 28.61 with a total of 889,050 shares traded.
Over the past week, the price has changed by -13.85%, over one month by -3.54%, over three months by +12.99% and over the past year by -42.06%.

Is CRI a buy, sell or hold?

Carter’s has received a consensus analysts rating of 2.33. Therefor, it is recommend to sell CRI.

Strong Buy: 0
Buy: 0
Hold: 3
Sell: 2
Strong Sell: 1

What are the forecasts/targets for the CRI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	29.5	3.1%
Analysts Target Price	29.5	3.1%
ValueRay Target Price	27.5	-3.9%

CRI Fundamental Data Overview November 20, 2025

Market Cap USD = 1.04b (1.04b USD * 1.0 USD.USD)
P/E Trailing = 11.6016
P/E Forward = 13.587
P/S = 0.3672
P/B = 1.2874
P/EG = 1.81
Beta = 1.079
Revenue TTM = 2.83b USD
EBIT TTM = 144.7m USD
EBITDA TTM = 199.5m USD
Long Term Debt = 498.7m USD (from longTermDebt, last quarter)
Short Term Debt = 150.5m USD (from shortTermDebt, last quarter)
Debt = 1.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 994.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.03b USD (1.04b + Debt 1.18b - CCE 184.2m)
Interest Coverage Ratio = 4.66 (Ebit TTM 144.7m / Interest Expense TTM 31.0m)
FCF Yield = 4.52% (FCF TTM 92.0m / Enterprise Value 2.03b)
FCF Margin = 3.25% (FCF TTM 92.0m / Revenue TTM 2.83b)
Net Margin = 3.15% (Net Income TTM 89.1m / Revenue TTM 2.83b)
Gross Margin = 46.79% ((Revenue TTM 2.83b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 45.08% (prev 48.14%)
Tobins Q-Ratio = 0.82 (Enterprise Value 2.03b / Total Assets 2.47b)
Interest Expense / Debt = 0.61% (Interest Expense 7.17m / Debt 1.18b)
Taxrate = 21.85% (3.24m / 14.8m)
NOPAT = 113.1m (EBIT 144.7m * (1 - 21.85%))
Current Ratio = 2.26 (Total Current Assets 1.13b / Total Current Liabilities 501.7m)
Debt / Equity = 1.36 (Debt 1.18b / totalStockholderEquity, last quarter 864.6m)
Debt / EBITDA = 4.98 (Net Debt 994.2m / EBITDA 199.5m)
Debt / FCF = 10.81 (Net Debt 994.2m / FCF TTM 92.0m)
Total Stockholder Equity = 855.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.61% (Net Income 89.1m / Total Assets 2.47b)
RoE = 10.42% (Net Income TTM 89.1m / Total Stockholder Equity 855.1m)
RoCE = 10.69% (EBIT 144.7m / Capital Employed (Equity 855.1m + L.T.Debt 498.7m))
RoIC = 8.35% (NOPAT 113.1m / Invested Capital 1.35b)
WACC = 5.34% (E(1.04b)/V(2.22b) * Re(10.85%) + D(1.18b)/V(2.22b) * Rd(0.61%) * (1-Tc(0.22)))
Discount Rate = 10.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.77%
[DCF Debug] Terminal Value 65.48% ; FCFE base≈166.2m ; Y1≈142.1m ; Y5≈110.2m
Fair Price DCF = 36.20 (DCF Value 1.32b / Shares Outstanding 36.4m; 5y FCF grow -17.63% → 3.0% )
EPS Correlation: -46.07 | EPS CAGR: -33.69% | SUE: 0.11 | # QB: 0
Revenue Correlation: -26.06 | Revenue CAGR: -6.52% | SUE: -1.26 | # QB: 0

Additional Sources for CRI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle